You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Personalized cancer vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Cairo (Peptide cancer vaccine)

Recruiting
  • Hepatocellular Carcinoma
  • Peptide cancer vaccine
  • Cairo, Egypt
    Faculty of Medicine Ain Shams Research Institute- Clinical Resea
Aug 10, 2022

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

Not yet recruiting
  • Posto Perative Hepatocellular Carcinoma
  • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
  • (no location specified)
Feb 27, 2023

Cervical Cancer, Anal Cancer, Penile Cancer Trial in College Park (Personalized Chatbot Intervention, Non-Personalized Chatbot

Recruiting
  • Cervical Cancer
  • +2 more
  • Personalized Chatbot Intervention
  • +2 more
  • College Park, Maryland
    University of Maryland, College Park (Online Survey-Experiment)
Jul 17, 2023

Advanced Cancer Trial in San Diego (personalized vaccine, Pembrolizumab)

Active, not recruiting
  • Advanced Cancer
  • San Diego, California
    UCSD Medical Center
Sep 20, 2022

Pancreatic Adenocarcinoma Trial in Lausanne (Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC

Recruiting
  • Pancreatic Adenocarcinoma
  • Autologous Dendritic Cell Vaccine Loaded with Personalized Peptides (PEP-DC vaccine)
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jun 23, 2022

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Brain Cancer, Tumor Metastases Trial in Guangzhou (Personalized cellular vaccine)

Completed
  • Brain Cancer
  • Neoplasm Metastases
  • Personalized cellular vaccine
  • Guangzhou, Guangdong, China
    Guangdong 999 Brain Hospital
May 23, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Melanoma Trial in Australia, United States (mRNA-4157, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +21 more
Aug 23, 2022

Follicular Lymphoma Trial in Boston (Rituximab, Neo Vax, Pembrolizumab)

Recruiting
  • Follicular Lymphoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2022

Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

Completed
  • Urothelial/Bladder Cancer, Nos
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 7, 2022

Kidney Cancer Trial in Boston (NeoVax, Ipilimumab)

Recruiting
  • Kidney Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Triple Negative Breast Cancer, Triple Negative Breast Tumors, Triple-Negative Breast Cancer Trial (Personalized synthetic long

Withdrawn
  • Triple Negative Breast Cancer
  • +2 more
  • Personalized synthetic long peptide vaccine (Poly ICLC)
  • Poly ICLC
  • (no location specified)
Mar 9, 2022

Metastatic Colorectal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in

Recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

NSCLC Trial in Lausanne (Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine), Low dose

Recruiting
  • Non-small Cell Lung Cancer
  • Autologous dendritic cell vaccine loaded with personalized peptides (PEP-DC vaccine)
  • Low dose cyclophosphamide
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Jan 17, 2022

Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Recruiting
  • Gastric Cancer
  • +2 more
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, Beijing, China
    PLA General Hospital
Jan 27, 2022

Cancer of Gastrointestinal Tract Trial in La Jolla (personalized vaccine, Ipilimumab, Nivolumab)

Not yet recruiting
  • Cancer of Gastrointestinal Tract
  • personalized vaccine
  • +2 more
  • La Jolla, California
    University of California, San Diego
Nov 29, 2021

Resectable Esophageal Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Esophageal Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University
Mar 23, 2022

Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)

Not yet recruiting
  • Refractory Tumor
  • Solid Tumor
  • Dendritic Cell Vaccine
  • +2 more
  • Kaohsiung, Taiwan
  • +2 more
Mar 2, 2023

Pancreatic Cancer, Pancreatic Carcinoma Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Completed
  • Pancreatic Cancer
  • Pancreatic Carcinoma
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Resectable Pancreatic Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Pancreatic Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Gastric Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Not yet recruiting
  • Gastric Cancer
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital,
Jan 26, 2022

Carcinoma, Melanoma, Bladder Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine and their sensitized T cells

Not yet recruiting
  • Carcinoma
  • +3 more
  • Tumor antigen-sensitized DC vaccine and their sensitized T cells subcutaneous administration
  • Chengdu, Sichuan, China
    West China Hospital
Feb 10, 2022